Procept Biorobotics
PRCT
263 hedge funds and large institutions have $1.77B invested in Procept Biorobotics in 2025 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 110 increasing their positions, 59 reducing their positions, and 39 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
86% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 59
64% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 39
9% more funds holding
Funds holding: 242 → 263 (+21)
3.44% less ownership
Funds ownership: 103.96% → 100.52% (-3.4%)
14% less capital invested
Capital invested by funds: $2.06B → $1.77B (-$297M)
21% less call options, than puts
Call options by funds: $6.67M | Put options by funds: $8.42M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Asset Management
Paris,
France
|
+$66.4M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$43.2M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$40.4M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.9M |
| 5 |
Janus Henderson Group
London,
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$112M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$70.3M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$35.1M |
| 4 |
JP Morgan Chase
New York
|
-$18.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$16.7M |
PRCT Hedge Fund Activity: Q4 2025 in Review
263 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2025, worth a combined $1.77B — down 14% from $2.06B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new PRCT positions and 39 closed out — a net gain of 25 holders — while 110 added to existing stakes and 59 trimmed.
The largest buyer was BNP Paribas Asset Management, adding an estimated $66.4M. The largest seller was Fidelity Investments, cutting an estimated $112M.
- 263 institutional investors held Procept Biorobotics (PRCT) as of Q4 2025, up from 242 in Q3 2025.
- Funds reported $1.77B of Procept Biorobotics stock for Q4 2025, down 14% quarter-over-quarter.
- 64 funds opened new Procept Biorobotics positions in Q4 2025 and 39 closed out, a net change of +25 holders.
- The largest Procept Biorobotics buyer in Q4 2025 was BNP Paribas Asset Management, an estimated $66.4M added.
- The largest Procept Biorobotics seller in Q4 2025 was Fidelity Investments, an estimated $112M sold.
Based on aggregated 13F filings for Q4 2025.